Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
The U.S. Department of Defense funds more than 500 neurotrauma research projects totaling over $700 million. Yet there remains a large unmet medical need for effective treatments of traumatic brain injury (TBI), a major cause of disability and mortality. The U.S. Army's new strategic research plan for developing improved drug therapies for TBI is published in Journal of Neurotrauma, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available on the Journal of Neurotrauma website.
The U.S. Army Medical Research and Materiel Command (USAMRMC) established the Neurotrauma Pharmacology Workgroup to develop a strategic research plan that identifies the most critical research priority areas with the goal of improving patient outcomes after TBI.
The Workgroup's report, "Pharmacotherapy of Traumatic Brain Injury: State of the Science and the Road Forward, Report of the Department of Defense Neurotrauma Pharmacology Workgroup," was coauthored by Ramon Diaz-Arrastia and Kimbra Kenney, Uniformed Services University of the Health Sciences (Bethesda, MD); Patrick Kochanek, University of Pittsburgh School of Medicine (PA); Peter Bergold, SUNY Downstate Medical Center (Brooklyn, NY); Christine Marx, Duke University Medical Center and Durham VA Medical Center (NC); Jamie Grimes, Defense and Veterans Brain Injury Center (Silver Spring, MD); Yince Loh, Madigan Army Medical Center (Tacoma, WA); Gina Adam, Kenneth Curley, and Wanda Salzer, U.S. Army MRMC (Ft. Detrick, MD); and Devon Oskvig (Rockville, MD).
John T. Povlishock, PhD, Editor-in-Chief of Journal of Neurotrauma and Professor, VCU Neuroscience Center, Medical College of Virginia, Richmond, notes that "although some of the themes advanced in this manuscript are not entirely new, the report helps to refocus current thought on those most critical research priority areas in the field of TBI pharmacological intervention. Additionally, the accompanying text addressing the current state of preclinical and clinical drug assessment will be an interesting read for all involved in this field of discovery."
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Neurology / Neuroscience category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Liebert, Mary Ann. "U.S. army identifies 6 critical research targets for improving outcomes in traumatic brain injury." Medical News Today. MediLexicon, Intl., 9 Jan. 2014. Web.
9 Mar. 2014. <http://www.medicalnewstoday.com/releases/270879>
Liebert, M. (2014, January 9). "U.S. army identifies 6 critical research targets for improving outcomes in traumatic brain injury." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/270879.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.